glp-1 and bariatric surgery The role of in postprandial glucose metabolism after surgery: a narrative review of human GLP-1 receptor antagonist studies Bariatric Surgery vs GLP-1 Medications
Description
of the human body (ref.4,9,10)

If your A1C is more than 1.5 percent above your target, a combination medication therapy is now the most common strategy per the standards of the American Diabetes Association. Combination medication therapy means taking more than one diabetes drug at once
How to Reduce the Risk Watch for symptoms

Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and -synuclein accumulation in the colon of two parkinsons disease mouse models

Typically, payers have justified covering GLP-1 therapies by targeting co-morbidities rather than obesity alone

Reduced glucose levels can also increase the production of ROS causing oxidation damage and interfere with signaling pathways and finally lead to apoptosis and necrosis [16] (Fig
